- Home
- EVGR vs RLMD Comparison
EVGR vs RLMD Comparison
Compare EVGR & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGR
- RLMD
- Stock Information
- Founded
- EVGR 2021
- RLMD 2004
- Country
- EVGR Malaysia
- RLMD United States
- Employees
- EVGR N/A
- RLMD N/A
- Industry
- EVGR Blank Checks
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- EVGR Finance
- RLMD Health Care
- Exchange
- EVGR Nasdaq
- RLMD Nasdaq
- Market Cap
- EVGR 94.7M
- RLMD 110.6M
- IPO Year
- EVGR 2022
- RLMD N/A
- Fundamental
- Price
- EVGR $11.83
- RLMD $0.36
- Analyst Decision
- EVGR
- RLMD Hold
- Analyst Count
- EVGR 0
- RLMD 3
- Target Price
- EVGR N/A
- RLMD $5.33
- AVG Volume (30 Days)
- EVGR 774.0
- RLMD 2.1M
- Earning Date
- EVGR 10-10-2024
- RLMD 11-07-2024
- Dividend Yield
- EVGR N/A
- RLMD N/A
- EPS Growth
- EVGR 3.29
- RLMD N/A
- EPS
- EVGR 0.28
- RLMD N/A
- Revenue
- EVGR N/A
- RLMD N/A
- Revenue This Year
- EVGR N/A
- RLMD N/A
- Revenue Next Year
- EVGR N/A
- RLMD N/A
- P/E Ratio
- EVGR $42.51
- RLMD N/A
- Revenue Growth
- EVGR N/A
- RLMD N/A
- 52 Week Low
- EVGR $11.14
- RLMD $0.35
- 52 Week High
- EVGR $11.83
- RLMD $7.22
- Technical
- Relative Strength Index (RSI)
- EVGR 75.99
- RLMD 16.59
- Support Level
- EVGR $11.73
- RLMD $0.35
- Resistance Level
- EVGR $11.78
- RLMD $0.41
- Average True Range (ATR)
- EVGR 0.00
- RLMD 0.16
- MACD
- EVGR 0.00
- RLMD -0.11
- Stochastic Oscillator
- EVGR 100.00
- RLMD 0.38
About EVGR Evergreen Corporation
Evergreen Corp is a blank check company.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.